Strategic partnerships HSG actively engages in collaborations with leading institutions and industry players (e.g., Vanderbilt University Medical Center, HD Genetics, Neurocrine Biosciences) which signals openness to co-sponsorships, data sharing agreements, and joint study opportunities that can be leveraged for new trials or patient recruitment programs.

Global trial network With a world-class, 800+ expert network across 130+ credentialed sites, HSG offers scalable access to Huntington’s disease patient cohorts, enabling rapid site activation, multi-site studies, and broader geographic enrollment for sponsors seeking diverse populations.

Clinical operations leadership Recent leadership appointment of an Executive Director of Clinical Operations and a longstanding nonprofit structure highlight strong governance and operational maturity, which can reassure sponsors about project management, timelines, and compliance for complex HD trials.

Education and engagement HSG’s CME4HD program and ongoing educational initiatives create opportunities for sponsor-supported training, investigator engagement, and patient/clinician outreach that can be integrated into study logistics, site motivation, and patient retention strategies.

Funding and visibility Active press and industry collaboration history, including notable PR and trial partnerships, indicates solid market visibility and potential for co-funded studies, grant-supported research, or sponsorships that can broaden sponsor branding and patient recruitment channels.